Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyze the weekly Hong Kong Connect flows with our data engine.</li>
<li>The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.</li>
<li>We highlight sound bound purchases of Li Ning, Wuxi Biologics, HKEx, and China Mobile. </li>
</ul>


We analyze the weekly Hong Kong Connect flows with our data engine.
The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
We highlight sound bound purchases of Li Ning, Wuxi Biologics, HKEx, and China Mobile. 


Hong Kong Connect Flows: What Chinese Bought for Rebound?

<ul>
<li>We analyze the weekly Hong Kong Connect flows with our data engine.</li>
<li>The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.</li>
<li>We highlight inflows into Meituan, Tencent, Li Ning, Kuaishou, and Xiaomi.</li>
</ul>


We analyze the weekly Hong Kong Connect flows with our data engine.
The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
We highlight inflows into Meituan, Tencent, Li Ning, Kuaishou, and Xiaomi.


Hong Kong Connect Flows: 3 Weeks of Inflows Despite Volatility

HK/China Equity Long-Short

Osbert Tang, CFA

Thematic (Sector/Industry)

<ul>
<li>The sharp surge in Omicron-driven local cases has driven more stringent measures by local governments. On ground in Shanghai, we see more tightened measures being implemented over the weekend. </li>
<li>The measures will reduce a lot of foot traffic and lower discretionary spending appetite in Mar, and this will negatively weigh on many 1Q22 results to be announced in late-Apr. </li>
<li>We advocate a long staples, short discretionary strategy in the near term. Also, travel sector will be hit, and on net-net basis, <a href="https://www.smartkarma.com/entities/meituan-dianping" target="_blank" data-smartkarma-citation="entities:26970:1" rel="noopener">Meituan (3690 HK)</a> looks to be a loser.</li>
</ul>


The sharp surge in Omicron-driven local cases has driven more stringent measures by local governments. On ground in Shanghai, we see more tightened measures being implemented over the weekend. 
The measures will reduce a lot of foot traffic and lower discretionary spending appetite in Mar, and this will negatively weigh on many 1Q22 results to be announced in late-Apr. 
We advocate a long staples, short discretionary strategy in the near term. Also, travel sector will be hit, and on net-net basis, Meituan (3690 HK) looks to be a loser.


China on the Ground: Escalating Measures to Combat Omicron and What Stocks Are Impacted?

Asian Insight Provider - Actionable ideas, CrossASEAN Research

Henry Soediarko

Asian Insight Provider - Actionable ideas

CrossASEAN Research

At CrossASEAN Research we strive to produce unbiased and differentiated on the ground insights on companies across South East Asia. Our Research is produced for the most part after face to face meetings and conversations with company management to dig deep into the long term vision and strategy of the companies we cover. We seek to deliver investable and actionable themes on sectors and markets across SE Asia, often in collaboration with other Insight Providers across the region, pooling the vast experience of the analysts within the Smartkarma Ecosystem. We also offer bespoke work and tailor made trips for our clients. 

Insights across South East Asia

Equity Bottom-Up

<ul>
<li>Norges Bank excludes <a href="https://www.smartkarma.com/entities/li-ning-co-ltd" target="_blank" data-smartkarma-citation="entities:6047:1" rel="noopener">Li Ning (2331 HK)</a> from its list due to poor labor practices/human rights issues.</li>
<li>Today's share price could be a telltale sign of the near-term prospect, down when the majority are up. </li>
<li>Will the other international shareholders follow suit on dumping the shares because of the human rights abuse? Potentially yes. </li>
</ul>


Norges Bank excludes Li Ning (2331 HK) from its list due to poor labor practices/human rights issues.
Today's share price could be a telltale sign of the near-term prospect, down when the majority are up. 
Will the other international shareholders follow suit on dumping the shares because of the human rights abuse? Potentially yes. 


Forensic Analyst

Jason Yap, CFA

Forensic Accounting

Anta Sports Products / Forensic Accounting

<ul>
<li>Anta benefits from strong tailwinds of the two Olympic events and the Chinese government's support for citizens' sports engagement</li>
<li>Anta's inventory position has improved relative to H1 2020. However, it remains weaker than pre-pandemic levels in 2019</li>
<li>We analyse Anta's inventory and highlight key factors to watch in its upcoming FY2021 results</li>
</ul>


Anta benefits from strong tailwinds of the two Olympic events and the Chinese government's support for citizens' sports engagement
Anta's inventory position has improved relative to H1 2020. However, it remains weaker than pre-pandemic levels in 2019
We analyse Anta's inventory and highlight key factors to watch in its upcoming FY2021 results


Anta (2020 HK) Inventory Analysis - Structural Tailwinds from the Olympics

China

Li Ning Company Limited researches, designs, manufactures, distributes, and retails sports footwear, apparel and accessories for sport and leisure use.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Li Ning (2331 HK)

Hong Kong Connect Flows: What Chinese Bought for Rebound?

We highlight weekly Hong Kong Connect sound bound inflows into Li Ning, Wuxi Biologics, HKEx, and China Mobile. We also noticed huge southbound...

Ke Yan, CFA, FRM

Hong Kong Connect Flows: 3 Weeks of Inflows Despite Volatility

We highlight three weeks of southbound inflows from mainland China and inflows into Meituan, Tencent, Li Ning, Kuaishou, and Xiaomi.

Ke Yan, CFA, FRM

China on the Ground: Escalating Measures to Combat Omicron and What Stocks Are Impacted?

Omicron combating measures have been stepped up over the weekend and this will make a dent on the Mar operations of many companies. This will be...

Osbert Tang, CFA

Li Ning (2331): SWF Exclusion

Not much positivity can come out of being excluded because of poor labor practice especially when it comes from a large and influential sovereign...

Henry Soediarko

Anta (2020 HK) Inventory Analysis - Structural Tailwinds from the Olympics

Anta benefits from strong tailwinds of the Olympics and the Chinese government's support for sports engagement. We analyse its inventory position...

Jason Yap, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)